Since the best clinical response to dupilumab is achieved after 12-16 weeks, a combination therapy at the beginning of the treatment could be a helpful strategy to reach a faster response in patients with severe atopic dermatitis (AD).
A Short Cycle of Narrow-Band UVB Phototherapy in the Early Phase of Dupilumab Therapy Can Provide a Quicker Improvement of Severe Atopic Dermatitis
Rossi, Mariateresa;Rovati, Chiara;Arisi, Mariachiara;Tomasi, Cesare;Calzavara-Pinton, Irene;Venturini, Marina;Calzavara-Pinton, Piergiacomo
2021-01-01
Abstract
Since the best clinical response to dupilumab is achieved after 12-16 weeks, a combination therapy at the beginning of the treatment could be a helpful strategy to reach a faster response in patients with severe atopic dermatitis (AD).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dermatology_2021_407 (1).pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
699.93 kB
Formato
Adobe PDF
|
699.93 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
